Feasibility Clinical Evaluation of the Calibreye System

NCT05885022 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-12-15

No results posted yet for this study

Summary

To evaluate the safety and feasibility of the Calibreye System in patients with open angle glaucoma.

Conditions

  • Glaucoma, Open-Angle

Interventions

DEVICE

Calibreye System

Implantation of a glaucoma device to reduce intraocular pressure

Sponsors & Collaborators

  • Myra Vision Inc.

    lead INDUSTRY

Principal Investigators

  • Keith Barton, MD · Moorfields Eye Hospital NHS Foundation Trust

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-31
Primary Completion
2027-12-31
Completion
2028-12-31
FDA Device
Yes

Countries

  • India
  • Mexico
  • Panama

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05885022 on ClinicalTrials.gov